• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR Back to Search Results
Catalog Number UNK CDS
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Hemorrhage/Bleeding (1888); Unspecified Infection (1930); Renal Failure (2041); Cardiac Tamponade (2226); Vascular Dissection (3160); Heart Failure/Congestive Heart Failure (4446); Mitral Valve Insufficiency/ Regurgitation (4451)
Event Date 09/04/2023
Event Type  Injury  
Event Description
This prospective study aimed to conduct a clinical process cost analysis to evaluate all upcoming costs of mitral valve transcatheter edge-to-edge repair (m-teer).Between 2020 and 2021, 51 patients were treated using the pascal system, and 56 were treated using the mitraclip system.All mitraclip patients had technical success.The following adverse effects that were reported: minor bleeding complication, major vascular complication, pneumonia, acute kidney failure.Major bleeding complications mainly occurred at access sites closed by a z-shaped suture and were successfully managed by manual compression.After the one-year follow-up period, hospitalization for heart failure occurred.A retrospective analysis was conducted on 709 m-teer patients treated between the years 2010 and 2020, and m-teer-related complications were rare but were associated with higher costs, mainly due to prolonged hospitalization.The analysis focused on m-teer-related complications and their associated costs, including pericardial tamponade, stroke, acute kidney injury (aki), bleeding, and vascular complications.Hemodialysis was required in 2 out of 70 patients with aki.In three patients, pericardiocentesis was performed during the procedure and in one patient after the procedure.Minor and major bleeding occurred, requiring transfusion of packed red blood cells.This analysis provides valuable insights into reducing expenses by modifying the process of m-teer.Details are listed in the attached article titled, "comparison of costs associated with transcatheter mitral valve repair: pascal vs mitraclip in a real-world setting, bmc health services.".
 
Manufacturer Narrative
B3: date of event is estimated.D4: the udi number is not known as the part and lot numbers were not provided.D6: the implant date is estimated.The device was not returned for analysis and a review of the lot history record and similar complaint review could not be performed as the part and lot number regarding the complaint device was not provided.The investigation was unable to determine a cause for the reported mr, hemorrhage, infection, renal failure, cardiac tamponade, heart failure, cerebrovascular accident, and vascular dissection.Mr, hemorrhage, infection, renal failure, cardiac tamponade, heart failure, cerebrovascular accident, and vascular dissection are listed in the instructions for use as known possible complications associated with the mitraclip procedures.The reported hospitalization and unexpected medical interventions were results of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key17913505
MDR Text Key325406290
Report Number2135147-2023-04454
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 10/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK CDS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/16/2023
Initial Date FDA Received10/11/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age79 YR
Patient SexMale
-
-